Last ¥268.00 JPY
Change Today +4.00 / 1.52%
Volume 22.0K
4512 On Other Exchanges
Symbol
Exchange
Tokyo
As of 2:00 AM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - WAKAMOTO PHARM CO LTD (4512)

Wakamoto Pharmaceutical Co., Ltd. to Report Fiscal Year 2014 on May 15, 2014
CapIQ 05/15/2014 4:00 AM ET
Wakamoto Pharmaceutical Co., Ltd. to Report Q3, 2014 on Feb 05, 2014
CapIQ 05/15/2014 4:00 AM ET
Wakamoto Pharmaceutical Co., Ltd. to Report Q2, 2014 on Oct 31, 2013
CapIQ 05/15/2014 4:00 AM ET

2014 revenues at Wakamoto Pharmaceutical Co., Ltd. totaled ¥10.3B JPY, while

Quarterly Earnings & Estimates - WAKAMOTO PHARM CO LTD (4512)

Chart not available

Wakamoto Pharmaceutical Co., Ltd.'s Quarterly Earnings

Wakamoto Pharmaceutical Co., Ltd. reported 1st quarter 2015 on 08/2/2014.

Annual Earnings & Estimates - WAKAMOTO PHARM CO LTD (4512)

Chart not available

Wakamoto Pharmaceutical Co., Ltd.'s Annual Earnings

Wakamoto Pharmaceutical Co., Ltd. reported annual 2014 on 05/17/2014.

Quarterly Revenues - WAKAMOTO PHARM CO LTD (4512)

Actuals vs. Estimates for WAKAMOTO PHARM CO LTD 4512

Wakamoto Pharmaceutical Co., Ltd.'s Quarterly Revenues

Wakamoto Pharmaceutical Co., Ltd. had 1st quarter 2015 revenues of ¥2.6B JPY. This was 3.7% above the prior year's 1st quarter results.

Annual Revenues - WAKAMOTO PHARM CO LTD (4512)

Actuals vs. Estimates for WAKAMOTO PHARM CO LTD 4512

Wakamoto Pharmaceutical Co., Ltd.'s Annual Revenues

Wakamoto Pharmaceutical Co., Ltd. had revenues for the full year 2014 of ¥10.3B JPY. This was 3.9% above the prior year's results.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4512:JP ¥268.00 JPY +4.00

4512 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4512.
View Industry Companies
 

Industry Analysis

4512

Industry Average

Valuation 4512 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.8x
Price/Book 0.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WAKAMOTO PHARM CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.